When does an app need FDA’s blessing?
Some apps help people look up symptoms, check drug side effects or locate. Some even measure blood pressure and blood sugar and send the readings off to the doctor. As a result, the Food and Drug Administration has concluded that at least some apps should undergo review by the agency before being permitted on the market. Dr. Jeffrey Shuren, who heads the FDA's Center for Devices and Radiological Health, stresses that the FDA has no plans to review most apps, such as those that help with wellness, healthier lifestyles. Same goes for those used to help patients manage their medical conditions. "The risk to patients are very, very low," he says.
- How One Health System Saved $3.5M in Benefits Costs
- Federal Appeals Court Mulls Observation Status
- Ebola: Lawmakers, Healthcare Leaders Clash Over Quarantines
- How the Military's EHR Reboot Will Impact Interoperability
- HCA to Acquire CareNow Urgent Care Centers
- 'Leadership Gap' Threatens MU Momentum, Says AMA
- Ebola: Nurses Demand 'Tools We Need' to Fight Infection
- Investing in Population Health Strategies Creates Financial Risk
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- BCBS Tries New Drug Contracting Model